Now showing items 1-3 of 3

    • Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new 

      Elwy, M.A.; Galal, Z.A.; Hasan, H.E. (‎2010)‎
      This study assessed the utility of some novel inflammatory markers compared with traditional laboratory markers in patients with systemic lupus erythematosus [‎SLE]‎. In a cohort of 43 SLE patients [‎19 with inactive and 24 with active SLE]‎ and 20 healthy controls, serial measures of soluble vascular cell adhesion molecule [‎sVCAM-1]‎ were significantly associated with SLE disease activity, scored using the British Isles Lupus Assessment Group index. Inflammatory markers neopterin and soluble intercellular adhesion molecule [‎sICAM-1]‎ appeared to be ...
    • Report on a collaborative study for proposed 1st WHO international standard for Lupus (‎anti-dsDNA)‎ antibodies (‎15/174)‎ 

      World Health Organization; WHO Expert Committee on Biological Standardization; Adrian Bristow; Bernard Fox; Carl Dolman; Susan J Thorpe; Peter Rigsby; Jason Hockley; Johan Rönnelid; Pier Luigi Meroni (‎WHO/BS/2017.2306, 2017)‎
    • [‎Systemic lupus erythematosus and Epstein-Barr virus]‎ 

      Tazi, I.; Fehri, S.; Elghrari, K.; Ouazzani, T.; Benchemsi, N. (‎2009)‎
      We determined the prevalence of antibodies to Epstein-Barr virus [‎EBV]‎ in 44 patients with systemic lupus erythematosus [‎SLE]‎ and 44 healthy blood donors matched for sex and age as controls. Of the cases, 39 were women; mean age was 33 years. Four cases [‎9%]‎ and 5 controls [‎11%]‎ were positive for IgM anti-viral capsid antigen [‎VCA]‎ [‎P = 0.9]‎. All the cases were positive for IgG anti-VCA compared with 91% of the controls [‎P = 0.12]‎. The mean immunity ratio for this antibody was 2.341 in cases and 1.873 in controls [‎P = 0.068]‎. Forty [‎91%]‎ cases ...